• OPEN AN ACCOUNT
Indian Indices
Sensex
76,765.92 -69.86
( -0.09%)
Global Indices
Nasdaq
52,223.83 255.58
(0.49%)
Dow Jones
7,434.43 1.45
(0.02%)
Hang Seng
62,158.55 -2,772.64
(-4.27%)
Nikkei 225
10,879.18 97.43
(0.90%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

modern engineering & projects limited
Glenmark USA launches Olanzapine for Injection
Jul 06,2026

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Olanzapine for Injection, 10 mg/vial, Single-Dose Vial. Glenmark's Olanzapine for Injection is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa®2 IntraMuscular Injection 10 mg/vial, of Cheplapharm Registration GmbH [NDA 021253].

According to IQVIA® sales data for the 12-month period ending May 2026, the Zyprexa® IntraMuscular Injection market achieved annual sales of approximately $25.4 million.